Patients with very early-onset systemic juvenile idiopathic arthritis exhibit more inflammatory features and a worse outcome

Journal of Rheumatology

Volumn 40, Issue 3, 2013, Pages 329-334

  Russo, Ricardo A G ^a   Katsicas, María M ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Damage; Disability; Outcome measures; Systemic juvenile systemic arthritis

Indexed keywords

BIOLOGICAL PRODUCT; CORTICOSTEROID; HEMOGLOBIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; B LYMPHOCYTE; CHILD; CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; FEMALE; GROWTH RETARDATION; HEMOGLOBIN BLOOD LEVEL; HEPATOMEGALY; HIP DISEASE; HUMAN; INFANT; INFLAMMATION; JOINT DESTRUCTION; JUVENILE ARTHRITIS DAMAGE INDEX; JUVENILE RHEUMATOID ARTHRITIS; LYMPHOCYTE DEPLETION; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; THROMBOCYTE COUNT;

ADOLESCENT; AGE FACTORS; AGE OF ONSET; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; INFLAMMATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84874862892     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120386     Document Type: Article

References (26)

1. Woo P. Systemic juvenile idiopathic arthritis: Diagnosis, management, and outcome. Nat Rev Rheumatol 2006;2:28-34.
2. Schneider R, Laxer RM. Systemic onset juvenile rheumatoid arthritis. Baillieres Clin Rheumatol 1998;12:245-71.
3. Schneider R, Lang BA, Reilly BJ, Laxer RM, Silverman ED, Ibanez D, et al. Prognostic indicators of joint destruction in systemic onset juvenile rheumatoid arthritis. J Pediatr 1992;120:200-5.
4. Modesto C, Woo P, García-Consuegra J, Merino R, García-Granero M, Arnal C, et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol 2001;19:211-7.
5. Ogilvie EM, Fife MS, Thompson SD, Twine N, Tsoras M, Moroldo M, et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children. Arthritis Rheum 2003;48:3202-6.
6. Petty RE, Cassidy JT. Systemic arthritis. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology. 5th ed. Philadelphia: Elsevier Saunders; 2005:291-303.
7. Gutierrez K. Bone and joint infections in children. Pediatr Clin N Am 2005;52:779-94.
8. Jaspan HB, Lawn SD, Safrit JT, Bekker LG. The maturing immune system: Implications for development and testing HIV-1 vaccines for children and adolescents. AIDS 2006;20:483-94.
9. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
10. Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: A retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000;27:491-6.
11. Moroldo MB, DeCunto C, Hubscher O, Liberatore D, Palermo R, Russo R, et al. Cross-cultural adaptation and validation of an Argentine-Spanish version of the Stanford Childhood Health Assessment Questionnaire (CHAQ). Arthritis Care Res 1998;11:382-90.
12. Wallace CA, Ruperto N, Giannini EH. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
13. Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 2005;52:2092-102.
14. Spiegel LR, Schneider R, Lang BA, Birdi N, Silverman ED, Laxer RM, et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis. A multicenter cohort study. Arthritis Rheum 2000;43:2402-9.
15. Oen K, Reed M, Malleson PN, Cabral DA, Petty RE, Rosenberg AM, et al. Radiographic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003;30:832-40.
16. Magni-Manzoni S, Rossi F, Pistorio A, Temporini F, Viola S, Beluffi G, et al. Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. Arthritis Rheum 2003;48:3509-17.
17. Sandborg C, Holmes TH, Lee T, Biederman K, Bloch DA, Emery H, et al. Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. J Rheumatol 2006; 33:2322-9.
18. Singh-Grewal D, Schneider R, Bayer N, Feldman BM. Predictors of disease course and remission in systemic juvenile idiopathic arthritis. Arthritis Rheum 2006;54:1595-601.
19. Russo RAG, Katsicas MM. Global damage in systemic juvenile idiopathic arthritis: Preliminary early predictors. J Rheumatol 2007;35:1151-6.
20. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Reed M, et al. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: Subset-specific correlations. J Rheumatol 2003;30:585-93.
21. Mellins ED, Macaubas C, Grom AA. Pathogenesis of systemic juvenile idiopathic arthritis: Some answers, more questions. Nat Rev Rheumatol 2011;7:416-26.
22. Frosch M, Foell D, Ganser G, Roth J. Arthrosonography of hip and knee joints in the follow up of juvenile rheumatoid arthritis. Ann Rheum Dis 2003;62:242-4.
23. Argyropoulou MI, Fanis SL, Xenakis T, Efremidis SC, Siamopoulou A. The role of MRI in the evaluation of hip joint disease in clinical subtypes of juvenile idiopathic arthritis. Br J Radiol 2002;75:229-33.
24. Russo RA, Katsicas MM. Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents. J Rheumatol 2009;36:1078-82.
25. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: A randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 2008;371:998-1006.
26. Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: Report of forty-six patients from an international multicenter series. Arthritis Rheum 2011;63:545-55.